Overview | Grand Rounds | Projects | Cores | Researchers & Staff | Training | Publications
 Community | International Research | Videos | FAQs | E-Newsletters

 WINTER 2007

E-Newsletter: Volume 1, No. 1
• Acute HIV Infection • Acute HIV Studies • HIV Action Research Network • New HIV Center Studies • News Briefs •

Acute HIV Infection: An Emerging Priority in HIV Prevention

HIV (red) attacking a T-cell

Prevention counselors have long called it the "window period" -- the brief time, lasting a few weeks or months, between when someone is infected and when he or she begins to test positive on HIV-antibody tests. For most of the last 20 years, this window period has been viewed as a complicating factor in HIV prevention counseling, since the results of any one HIV test cannot be viewed as definitive proof that an individual is not actually infected.

More recently, however, researchers have begun to focus on a far more epidemiologically significant aspect of the window period. In part because the body has not yet mounted an effective antibody reaction to HIV during the first days and weeks after infection, the virus replicates rapidly, largely unchecked by the immune system. Whereas viral loads under 1,000 are generally considered low, and viral loads above 100,000 are seen as possible reason to begin antiretroviral treatment, people newly infected with HIV can have viral loads in the millions. Thus, during this brief but crucial period, blood and genital secretions are highly infectious to others – at the very time that people are unaware of their infection and have, by definition, recently engaged in unprotected sexual or drug using behavior.

For some time, medical science has been aware of the high viral load found during the acute phase of HIV infection, as well as the accompanying flu-like symptoms sometimes called "seroconversion syndrome." It is only fairly recently, however, that behavioral scientists have focused on the public health implications of acute HIV infection (AHI) and to begin research into the development of preventive interventions.

"The data are not definitive, but some studies suggest that as many as 50 percent of new infections may be traced to people who were acutely infected and, thus, highly infectious and probably didn't even know that they were infected," said HIV Center Investigator Robert Remien, who has studied AHI. "So, if as many as half of new infections in this country now are occurring during this time period, interventions could have a very big impact on transmission."

In all, a strong empirical rationale has emerged for focusing on the acute period of HIV infection, and New York and other states are grappling with questions regarding guidelines for HIV testing and other policies. For instance, early detection of new HIV infections may provide opportunities for immediate prevention and treatment counseling for the newly infected individual, as well as quick contact tracing, partner notification, and risk-reduction counseling for at-risk partners. Such prompt intervention, particularly those that tap into high-risk sexual and drug-using networks, could help to break the chain of new infections.

"The clinical advantage of treating people with acute HIV infection is not yet firmly established, but it's certainly beneficial to get people into care early and be able to follow them closely," noted Dr. Alan Berkman, a physician who also studies AHI at the HIV Center. "We may find out in the next year or two that there are definite benefits from starting people with acute infection on treatment, and that will make it even more compelling to be able to identify those individuals."

-- by Raymond A. Smith